QurAlis NEWS

QurAlis Launches with Seed Funding from MPH, Amgen and Alexandria, united in the fight to cure ALS

April 5, 2018

CAMBRIDGE, Mass., April 5, 2018. QurAlis Corporation, a new private biotech company focused on developing precision solutions to cure ALS, today announced the addition of biotech investors MP Healthcare Venture…

Read More

QurAlis has won the Amgen Golden Ticket at LabCentral

December 15, 2017

CAMBRIDGE, Mass., Dec. 15, 2017 QurAlis was chosen by an Amgen internal committee and live audience members at a “Quick Pitch” event hosted by Amgen at its Cambridge R&D and Operations…

Read More

ALS News Today

Ice Bucket Dollars at Work: Researchers Explore Promising New Way to Treat ALS

April 20, 2018

Read More

#AAN2018 – H.P. Acthar Gel Shows Promise as Therapy to Delay Progression of ALS

April 20, 2018

Read More

#AAN2018 – New Molecular Therapies May Be Treatment Strategy for ALS, Study Suggests

April 19, 2018

Read More

Lauren Sciences Awarded Third Grant for Development of Potential ALS Therapeutic

April 18, 2018

Read More

#AAN2018: Variations of TP73 Gene May Increase Susceptibility to Non-inherited ALS, Study Reports

April 18, 2018

Read More

Dr. Peter Creigh Wants to Improve ALS Care Through Virtual Research Visits

April 17, 2018

Read More

How I Use ‘Showing Up’ to Help Me Live with ALS

April 17, 2018

Read More

#AAN2018 — NurOwn’s Beneficial Effect in ALS Sustained by miRNA Regulation, Study Suggests

April 17, 2018

Read More

Tailored Home Exercises May Improve Daily Living of Early-stage ALS Patients, Small Study Suggests

April 16, 2018

Read More

New Study Reveals Two Genes Associated with High Risk for ALS

April 13, 2018

Read More

1
2
3
…
10
Next »

JOIN US IN THE FIGHT AGAINST ALS

Whether you or a loved one is battling ALS and you want to be a part of our clinical trials, or you want to invest in the fight against this debilitating disease, we want to hear from you. Fill out the form below today and we will get back to you as quickly as possible.